Insider · CIK 0001729765
Kathryn Fahy
Files at HNNA (HENNESSY ADVISORS INC). First filing Feb 27, 2025, latest May 12, 2026.
In brief
Kathryn Fahy files SEC Form 4 as CFO at HNNA (HENNESSY ADVISORS INC). Since Feb 27, 2025, Kathryn Fahy has reported 0 open-market buys worth $0 and 3 open-market sells worth $296k, the latest filed on May 12, 2026.
A track record needs three past buys with six months of prices behind them; Kathryn Fahy has 0, so none is measured yet.
The newest scored trade: sold $100k of HNNA on May 11, 2026, filed May 12, 2026, scored 37 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $100k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HNNA: HENNESSY ADVISORS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | HNNAsell HENNESSY ADVISORS INC | $100k 10,000 shares | -14% | +17% from low-18% from high | |
| 37Weak | HNNAsell HENNESSY ADVISORS INC | $107k 10,000 shares | -13% | +18% from low-22% from high | |
| 31Weak | HNNAsell HENNESSY ADVISORS INC | $89k 8,000 shares | -10% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 11, 2026 | HNNA HENNESSY ADVISORS INC | 10,000 0.13% of outstanding | $102k | May 11, 2026 | none |
| May 13, 2025 | HNNA HENNESSY ADVISORS INC | 10,000 0.13% of outstanding | $108k | May 13, 2025 | $89k |
| Feb 27, 2025 | HNNA HENNESSY ADVISORS INC | 8,000 0.10% of outstanding | $88k | Feb 27, 2025 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | HNNA HENNESSY ADVISORS INC | AGrant or award Common Stock | +12,500 | $0.00 | $0 | 73,189 | 21 d ago |
| Sep 18, 2026 | HNNA HENNESSY ADVISORS INC | FTax withholding Common Stock | -4,258 | $10.38 | $44k | 68,931 | 21 d ago |
| May 11, 2026 | HNNA HENNESSY ADVISORS INC | SOpen-market sale Common Stock | -10,000 | $10.00 | $100k | 60,689 | May 12, 2026 |
| Dec 10, 2025 | HNNA HENNESSY ADVISORS INC | GGift Common Stock | -2,000 | $0.00 | $0 | 70,689 | Dec 11, 2025 |
| Sep 18, 2025 | HNNA HENNESSY ADVISORS INC | AGrant or award Common Stock | +12,500 | $0.00 | $0 | 76,711 | Sep 19, 2025 |
| Sep 18, 2025 | HNNA HENNESSY ADVISORS INC | FTax withholding Common Stock | -4,022 | $11.08 | $45k | 72,689 | Sep 19, 2025 |
| May 13, 2025 | HNNA HENNESSY ADVISORS INC | SOpen-market sale Common Stock | -10,000 | $10.71 | $107k | 64,211 | May 14, 2025 |
| Feb 27, 2025 | HNNA HENNESSY ADVISORS INC | SOpen-market sale Common Stock | -8,000 | $11.07 | $89k | 74,211 | Feb 27, 2025 |
Questions about Kathryn Fahy
Answered from the filings on this page, as of the latest one.
Is Kathryn Fahy buying or selling?
In the last 12 months Kathryn Fahy reported 0 open-market buys worth $0 and 1 open-market sell worth $100k on SEC Form 4; the latest was sold $100k of HNNA on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Kathryn Fahy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathryn Fahy has 0.
Where does Kathryn Fahy file Form 4?
Kathryn Fahy has filed Form 4 at HNNA (HENNESSY ADVISORS INC) as SVP and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.